Basic HTML Version
126
SCIENTIFIC REPORT 2012
Title:
Effect of optimized oxygen therapy on stress desaturation in patients with
interstitial lung disease (MPID).
District Attorney:
CRAMPID.
Principal Investigator:
Amàlia Moreno Gómez de Bonilla.
Title:
Cerebral alterations related to Ventilator Associated Pneumonia (VAP). Efficacy of two
different strategies for the prevention of VAP on brain status.
District Attorney:
CIR Scholarship.
Principal Investigator:
Elisa Quílez Tierno.
Title:
Teriparatide and Risedronate in the treatment of severe postmenopausal osteoporosis:
Comparative effects on vertebral fractures.
District Attorney:
Lilly SA
Principal Investigator:
Enrique Casado Burgos.
Title:
Variation of immune parameters after oral immunotherapy in allergic children a
cow's milk protein.
District Attorney:
CIR Scholarship.
Principal Investigator:
Jordi Costa Colomer.
Title:
Extension, multicenter, double-blind, randomized study of secukinumab
subcutaneous in pre-filled syringes to demonstrate long-term efficacy, safety and
tolerability up to 2 years in subjects with moderate to severe chronic plaque psoriasis
have completed previous phase III psoriasis studies with secukinumab.
District Attorney:
Novartis Farmacéutica SA
Principal Investigator:
Natala Fernández Chico.
Title:
Uncontrolled multicenter extension study evaluating the efficacy and safety of
SAR153191 together with Anti-Rheumatic Disease Modifying Drugs (FARMEs)
in patients with Rheumatoid Arthritis (RA).
District Attorney:
Sanofi-Aventis Research & Development.
Principal Investigator:
Antoni Gómez Centeno.